{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:33:33Z","timestamp":1767713613944,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.fjurol.2024.102571","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T05:11:56Z","timestamp":1707023516000},"page":"102571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10 years"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"Leclercq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Walz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L.","family":"Charvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gondran-Tellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Henri","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Long-Depaquit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pignot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.fjurol.2024.102571_bib0130","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102571_bib0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MOU.0000000000000157","article-title":"Observational studies and the natural history of screen-detected prostate cancer","volume":"25","author":"Albertsen","year":"2015","journal-title":"Curr Opin Urol"},{"issue":"12","key":"10.1016\/j.fjurol.2024.102571_bib0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.fjurol.2024.102571_bib0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.purol.2011.02.015","article-title":"Place de la surveillance active dans le cancer de la prostate \u00e0 faible risque de progression [Active surveillance for localized prostate cancer]","volume":"21","author":"Staerman","year":"2011","journal-title":"Prog Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102571_bib0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN guidelines insights: prostate cancer, version 1.2021","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102571_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102571_bib0160","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamainternmed.2022.7100","article-title":"Use of active surveillance vs definitive treatment among men with low- and favorable intermediate-risk prostate cancer in the US between 2010 and 2018","volume":"183","author":"Al Hussein Al Awamlh","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102571_bib0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euo.2019.04.006","article-title":"Trends in conservative management for low-risk prostate cancer in a population-based cohort of Australian men diagnosed between 2009 and 2016","volume":"4","author":"Ong","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"10.1016\/j.fjurol.2024.102571_bib0170","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamaoncol.2016.3600","article-title":"Uptake of active surveillance for very-low-risk prostate cancer in Sweden","volume":"3","author":"Loeb","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102571_bib0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00345-016-1897-0","article-title":"Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study","volume":"35","author":"Timilshina","year":"2017","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102571_bib0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102571_bib0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11845-013-1024-9","article-title":"A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland","volume":"183","author":"Forde","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102571_bib0190","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.02.020","article-title":"Medium-term outcomes of active surveillance for localised prostate cancer","volume":"64","author":"Selvadurai","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102571_bib0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.juro.2015.01.102","article-title":"Gleason upgrading with time in a large prostate cancer active surveillance cohort","volume":"194","author":"Jain","year":"2015","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102571_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.eururo.2012.11.005","article-title":"Active surveillance for low-risk prostate cancer worldwide: the PRIAS study","volume":"63","author":"Bul","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102571_bib0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","article-title":"Active Surveillance of Grade Group 1 Prostate Cancer: long-term outcomes from a large prospective cohort","volume":"77","author":"Tosoian","year":"2020","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.fjurol.2024.102571_bib0210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102571_bib0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102571_bib0220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2022.07.004","article-title":"Active surveillance for intermediate-risk prostate cancer: a systematic review, meta-analysis, and metaregression","volume":"5","author":"Baboudjian","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102571_bib0225","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"issue":"17","key":"10.1016\/j.fjurol.2024.102571_bib0230","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102571_bib0235","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s00330-020-07336-0","article-title":"MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance","volume":"31","author":"Caglic","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.fjurol.2024.102571_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.euros.2021.11.006","volume":"35","author":"Olivier","year":"2022","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102571_bib0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JU.0000000000001339","article-title":"The clinical significance of multiple negative surveillance prostate biopsies for men on active surveillance-does cancer vanish or simply hide?","volume":"205","author":"Chu","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102571_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2023.04.018","article-title":"Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer","author":"Salari","year":"2023","journal-title":"Urol Oncol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:23:57Z","timestamp":1757435037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2950393024000056"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102571","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102571"}}